Any current/future new fundraising through debt or equity?

No current or future fundraising through debt or equity was mentioned in the transcript. The company plans to fund its FY25 capex of Rs. 110 crores entirely through internal accruals. Cash and cash equivalents at the end of Q1 FY25 stood at Rs. 140 crores, supporting a cash surplus status. Management confirmed that India Pesticides Limited will remain a cash surplus company even after planned capex spending. There is no indication of plans for issuing new debt or equity in the near future based on the discussion.

Any current/future capex/capital investment/strategic investment?

India Pesticides Limited plans a capex of Rs. 110 crores for FY25, covering both the parent company (IPL) and its subsidiary Shalvis Specialties Limited (SSL) — Rs. 50 crores for IPL and Rs. 65 crores for SSL. The capex will fund expansion including commissioning new formulation plant capacity (expected within the current or next month) and intermediate plants, enhancing backward integration. New intermediate plants are being commissioned for backward integration of key fungicides previously imported. Additional active ingredients (two molecules) are being developed and plants for them are exp

Future growth expectations in sales/revenue/volumes?

India Pesticides expects sales growth of 15% to 20% for FY25 and similarly for FY26. Volume growth is a key driver, with FY25 growth mostly volume-led; price increases are difficult but possible later in the year. Q1 FY25 volume increased by 26% YoY, with a recovery seen especially in formulations. Capacity expansions in formulation plants (30%-40% increase) will support sales growth. Technical plant capacity currently at 66% utilization with plans to commission increased formulation capacity shortly. Domestic market expected to grow 8% to 10% annually, bolstered by newly introduced

Future growth expectations in earnings/operating earnings/profits/EPS?

EBITDA margin is expected to improve to around 18%-20% from Q3 FY25 onwards and remain in this range in FY26. Sales growth guidance for FY25 and FY26 is 15%-20%, primarily volume-led with potential upside from price increases. Domestic market sales expected to grow 8%-10% annually, supported by new product introductions. Formulation capacity will be expanded by 30%-40% to support growth; technical plant capacity is sufficient. New product contributions (including new molecules) are growing, with ~18%-19% revenue from new molecules in Q1 FY25. Company aims to maintain a cash-surplus p

Current/ Expected Orderbook/ Pending Orders?

As of Q1 FY25, India Pesticides has export orders worth approximately Rs. 100 crores pending. In Q1 FY25, the company supplied export material worth Rs. 78 crores. Export orders are gradually increasing, indicating pick-up in international market demand. The company expects export volumes and prices to improve in coming quarters, with prices currently settling after a decline. Domestic market demand remains strong, supported by a good Kharif sowing season.

IN US

Sale is live|00:00:00left today

India Pesticides LtdQ2 FY24Fertilizers & Agrochemicals

India Pesticides Ltd Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹161P/E: 16.9Market Cap: ₹1.9K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→India Pesticides expects sales growth of 15% to 20% for FY25 and similarly for FY26.
→Volume growth is a key driver, with FY25 growth mostly volume-led; price increases are difficult but possible later in the year.
→Q1 FY25 volume increased by 26% YoY, with a recovery seen especially in formulations.
→Capacity expansions in formulation plants (30%-40% increase) will support sales growth.
→Technical plant capacity currently at 66% utilization with plans to commission increased formulation capacity shortly.
→Domestic market expected to grow 8% to 10% annually, bolstered by newly introduced domestic-oriented products.
→Export volumes, previously declined due to channel inventory and adverse weather, are now picking up.
→New molecules contributed about 18%-19% of revenue this quarter, indicating a growing product mix.
→Overall, the company is confident in sustaining growth through capacity expansion, product mix improvement, and market recovery.

Margin guidance

Category 3

→EBITDA margin is expected to improve to around 18%-20% from Q3 FY25 onwards and remain in this range in FY26.
→Sales growth guidance for FY25 and FY26 is 15%-20%, primarily volume-led with potential upside from price increases.
→Domestic market sales expected to grow 8%-10% annually, supported by new product introductions.
→Formulation capacity will be expanded by 30%-40% to support growth; technical plant capacity is sufficient.
→New product contributions (including new molecules) are growing, with ~18%-19% revenue from new molecules in Q1 FY25.
→Company aims to maintain a cash-surplus position and fund Rs. 110 crores capex internally in FY25.
→Prices in international markets are stabilizing after a decline, with gradual recovery expected to support margin improvement.
→Return to historic high EBITDA margins (above 25%) is unlikely in near term; margins above 20% possible with market recovery.
→Overall, India Pesticides projects steady improvement in earnings and profitability driven by volume growth, capacity expansion, and gradual price recovery.

3 more insights locked — sign up free to unlock

Fundraise plans

→No current or future fundraising through debt or equity was mentioned in the transcript.
→The company plans to fund its FY25 capex of Rs. 110 crores entirely through internal accruals.
→Cash and cash equivalents at the end of Q1 FY25 stood at Rs. 140 crores, supporting a cash surplus status.
→Management confirmed that India Pesticides Limited will remain a cash surplus company even after planned capex spending.
→There is no indication of plans for issuing new debt or equity in the near future based on the discussion.

Order book

Yes

→As of Q1 FY25, India Pesticides has export orders worth approximately Rs. 100 crores pending.
→In Q1 FY25, the company supplied export material worth Rs. 78 crores.
→Export orders are gradually increasing, indicating pick-up in international market demand.
→The company expects export volumes and prices to improve in coming quarters, with prices currently settling after a decline.
→Domestic market demand remains strong, supported by a good Kharif sowing season.

Capex plans

Yes

→India Pesticides Limited plans a capex of Rs. 110 crores for FY25, covering both the parent company (IPL) and its subsidiary Shalvis Specialties Limited (SSL) — Rs. 50 crores for IPL and Rs. 65 crores for SSL.
→The capex will fund expansion including commissioning new formulation plant capacity (expected within the current or next month) and intermediate plants, enhancing backward integration.
→New intermediate plants are being commissioned for backward integration of key fungicides previously imported.
→Additional active ingredients (two molecules) are being developed and plants for them are expected to be commissioned by Q3 FY25.
→Capex funding will be primarily from internal accruals; the company expects to remain cash surplus even after capex.
→The Hamirpur technical plant is under construction and expected to be commissioned by Q3 FY25, contributing significantly to revenues next year.
→Strategic focus includes enhancing R&D, backward integration, and expanding product and formulation capacities.

How does India Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1India Pesticides Ltd

Rev 3Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like India Pesticides Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio